Eva Vilarrasa

Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting

Eva Vilarrasa, Pedro Herranz, L. Puig et al. · British Journal of Dermatology · 2012 · 99 citations

Medicine, Dermatology, Pharmacotherapy +14

The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study

Kelsey R. van Straalen, Thrasyvoulos Tzellos, Phillipe Guillem et al. · Journal of the American Academy of Dermatology · 2021 · 93 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Treatment of patients with plaque psoriasis with secukinumab in a real-life setting: a 52-week, multicenter, retrospective study in Spain

J. Notario, Gustavo Deza, Eva Vilarrasa et al. · Journal of Dermatological Treatment · 2018 · 74 citations

Medicine, Dermatology, Pharmacotherapy +13

ORBIT (Outcome and Retention Rate of Biologic Treatments for Psoriasis): A retrospective observational study on biologic drug survival in daily practice

Eva Vilarrasa, Jaume Notario, X. Bordas et al. · Journal of the American Academy of Dermatology · 2016 · 72 citations

Medicine, Dermatology, Pharmacotherapy +11

Adalimumab Dose Intensification in Recalcitrant Hidradenitis Suppurativa/Acne Inversa

Christos C. Zouboulis, Hendrik H.G. Hansen, Giovanni Damiani et al. · Dermatology · 2019 · 69 citations

Medicine, Pharmacology, Pharmacotherapy +13